Clinical Trials on Normal Human Subjects

Total 12287 results

Taiho Pharmaceutical Co., Ltd.

Completed

A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects

Healthy Male Subjects

Japan
GE Healthcare
PPD

Completed

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

Healthy Subjects (HS)

China
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers

Healthy Adult Subjects

China
Spanish National Research Council
Andalusian Health Service; Universidad Pablo de Olavide

Completed

Bioavailability of Oleanolic Acid Formulated as Functional Olive Oil (BIO-OLTRAD)

Healthy Subjects | Bioavailability

Spain
Taisho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of TS-142 in Healthy Adult Subjects.

Healthy Male Subjects

Japan
Connect Biopharma Australia Pty Ltd

Completed

Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Healthy Adult Subjects

Australia
Taiho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

Healthy Male Subjects

Japan
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects

Healthy Male Subjects

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

Healthy Male Subjects

China
Darnitsa Pharmaceutical Company
Anapharm Bioanalytics

Completed

Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Turkey
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Nobelpharma

Completed

A Study of NPC-22 in Healthy Adult Males

Healthy Adult Subjects

Japan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Saniona

Completed

Study to Investigate the Pharmacokinetic Profile

Healthy Male Subjects

Germany
Bausch Health Americas, Inc.

Withdrawn

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Methadone-maintenance Subjects

United States
Bausch Health Americas, Inc.

Completed

Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone

Metahdone-maintenance Subjects

United States
ARCIM Institute Academic Research in Complementary...
Universität Tübingen

Completed

Comparison of Pulse Wave and Blood Pressure Measurements Before, During and After Ergometry in Healthy Women

Healthy Female Subjects

Germany
Eli Lilly and Company
ARMO BioSciences

Completed

A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) (Willow 1)

Healthy Adult Subjects

United States
Exeltis France
Insud Pharma

Completed

Benznidazole Absorption, Metabolism and Excretion Study

Healthy Male Subjects

United Kingdom
HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Healthy Male Subjects

Korea, Republic of
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Mass Balance Study of FYU-981

Healthy Male Subjects

Japan
Rigshospitalet, Denmark

Completed

Effect of Sodium Nitroprusside on Cerebral Blood Flow

Healthy Male Subjects

Denmark
AstraZeneca

Completed

A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects

Healthy Subjects | Pharmacodynamics

United Kingdom
Bioblast Pharma Ltd.
Parexel

Completed

A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects

Healthy Volunteer Subjects

United States
Elysium Health
KGK Science Inc.

Completed

A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects. (15BSHE)

Safety: Healthy Subjects

Canada
Universidade Federal de Pernambuco

Unknown

Effects of Transcranial Direct Current Stimulation Associated With Physical Exercise: a Metaplasticity Study

Healthy Subjects | Metaplasticity

Brazil
Alcobra Ltd.

Completed

A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers

Healthy Adult Subjects

Israel
Astellas Pharma Inc

Completed

To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females

Healthy Subjects | Pharmacokinetics

Netherlands
Hanlim Pharm. Co., Ltd.

Completed

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

Healthy Male Subjects

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subjects

Healthy Adult Subjects

United States
Topcon Corporation

Completed

TRK-3 Performance of Pachymetry

Normal

United States
Mahidol University

Completed

Atopy Patch Test in Normal Population : Pilot Study

Normal

Thailand
Dokuz Eylul University

Recruiting

The Effects of Exercise on Gait Characteristics, Balance, and Performance in Patients With Normal Pressure Hydrocephalus

NPH (Normal Pressure Hydrocephalus)

Turkey
University of Zurich

Active, not recruiting

Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH (iNPH)

Idiopathic Normal Pressure Hydrocephalus

Switzerland
Second Affiliated Hospital, School of Medicine,...
Westlake University

Unknown

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

Idiopathic Normal Pressure Hydrocephalus

China
Translational Research Center for Medical Innovation...
Johnson & Johnson; Codman & Shurtleff; Eisai Limited; Nihon Medi-Physics Co., Ltd. and other collaborators

Completed

Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus

Idiopathic Normal Pressure Hydrocephalus

Japan
Indiana University

Withdrawn

System for Ocular Oxygen Measurement

Normal

United States
Pfizer

Completed

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery (FCAD02)

Cardiac Surgery Subjects | Subjects Undergoing CABG and/or Cardiac Valve Replacement

United States
Uppsala University Hospital
Uppsala University; Swedish Society for Medical Research

Recruiting

Acetazolamide Trial in Normal Pressure Hydrocephalus (DRAIN)

Idiopathic Normal Pressure Hydrocephalus (INPH)

Sweden
Johns Hopkins University
University of Utah; Integra LifeSciences Corporation

Completed

A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial (PENS)

Idiopathic Normal Pressure Hydrocephalus (INPH)

United States, Canada, Sweden
Johns Hopkins University
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Efficacy in iNPH Shunting (PENS) Trial (PENS)

Idiopathic Normal Pressure Hydrocephalus (INPH)

United States, Canada, Sweden
University of Zurich
ETH Zurich

Completed

Walking Pattern Characteristics in Normal Pressure Hydrocephalus (NPH wearables)

Idiopathic Normal Pressure Hydrocephalus (INPH)

Switzerland
Erasmus Medical Center
UMC Utrecht; Medtronic; Albert Schweitzer Hospital; Isala; University Medical Center... and other collaborators

Completed

A Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus

Idiopathic Normal Pressure Hydrocephalus

Netherlands
Mayo Clinic

Terminated

Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement

Normal Pressure Hydrocephalus Patients

United States
Umeå University

Completed

Improved Analysis Methods for Infusion Tests

Idiopathic Normal Pressure Hydrocephalus

Sweden
University of Wisconsin, Madison

Completed

Study: Manometry With & Without Lidocaine

Normal

United States
Reata, a wholly owned subsidiary of Biogen
Celerion; Q2 Solutions; Altasciences Company Inc.

Completed

An Open-label DDI Study of Omaveloxolone in Healthy Subjects

Healthy Adult Subjects

United States
Reata, a wholly owned subsidiary of Biogen
Covance

Completed

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

Healthy Adult Subjects

United States

Clinical Trials on Normal Human Subjects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations